BIOMARIN PHARMACEUTICAL INC Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations
BIOMARIN PHARMACEUTICAL INC (BMRN) reported Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations of $0 for the 12-month period ending 2024-12-31, per its 10-K filed 2025-02-24.
Financial Statements › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations · last filed 2025-02-24
- BIOMARIN PHARMACEUTICAL INC unrecognized tax benefits, reduction resulting from lapse of applicable statute of limitations for fiscal 2024 was $0.00.
- BIOMARIN PHARMACEUTICAL INC unrecognized tax benefits, reduction resulting from lapse of applicable statute of limitations for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- BIOMARIN PHARMACEUTICAL INC unrecognized tax benefits, reduction resulting from lapse of applicable statute of limitations for fiscal 2022 was $18.00K, a 90.11% decline from fiscal 2021.
- BIOMARIN PHARMACEUTICAL INC unrecognized tax benefits, reduction resulting from lapse of applicable statute of limitations for fiscal 2021 was $182.00K, a 31.88% increase from fiscal 2020.
| Period end | Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations 12 month |
|---|---|
| 2024-12-31 | $0.00 10-K · filed 2025-02-24 |
| 2023-12-31 | $0.00 10-K · filed 2025-02-24 |
| 2022-12-31 | $18.00K 10-K · filed 2024-02-26 |
| 2021-12-31 | $182.00K 10-K · filed 2023-02-27 |
| 2020-12-31 | $138.00K 10-K · filed 2022-02-25 |
| 2019-12-31 | $0.00 10-K · filed 2021-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |